Cigna Co. (NYSE:CI – Get Rating) SVP Hoeltzel Mary T. Agoglia sold 7,044 shares of the stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $286.89, for a total value of $2,020,853.16. Following the completion of the transaction, the senior vice president now directly owns 8,498 shares in the company, valued at $2,437,991.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Cigna Price Performance

Shares of NYSE:CI traded down $1.07 during midday trading on Thursday, hitting $286.00. The company had a trading volume of 1,820,097 shares, compared to its average volume of 1,765,573. Cigna Co. has a twelve month low of $191.74 and a twelve month high of $289.63. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.72 and a quick ratio of 0.72. The stock has a market cap of $87.26 billion, a price-to-earnings ratio of 17.05, a price-to-earnings-growth ratio of 1.12 and a beta of 0.73. The business's 50-day simple moving average is $266.54 and its 200-day simple moving average is $252.56.

Cigna (NYSE:CI – Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The health services provider reported $6.22 earnings per share for the quarter, beating analysts' consensus estimates of $5.62 by $0.60. Cigna had a return on equity of 15.91% and a net margin of 3.05%. The business had revenue of $45.48 billion during the quarter, compared to analysts' expectations of $44.34 billion. During the same period in the previous year, the firm posted $5.24 earnings per share. The company's revenue was up 5.4% on a year-over-year basis. On average, research analysts predict that Cigna Co. will post 23 earnings per share for the current year.

Cigna Announces Dividend

Analyst Ratings Changes

Several analysts recently commented on the company. JPMorgan Chase & Co. raised Cigna from a "neutral" rating to an "overweight" rating and raised their target price for the stock from $248.00 to $304.00 in a report on Monday, May 16th. The Goldman Sachs Group raised their target price on Cigna from $273.00 to $311.00 and gave the stock a "neutral" rating in a report on Tuesday. Raymond James raised their target price on Cigna from $275.00 to $300.00 in a report on Tuesday, May 10th. UBS Group raised their target price on Cigna from $310.00 to $330.00 and gave the stock a "buy" rating in a report on Monday. Finally, Sanford C. Bernstein raised their target price on Cigna from $258.00 to $301.00 and gave the stock a "mkt perform" rating in a report on Friday, May 27th. Seven research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Cigna presently has an average rating of "Moderate Buy" and an average price target of $304.67.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. State Street Corp boosted its holdings in Cigna by 1.1% in the fourth quarter. State Street Corp now owns 14,982,346 shares of the health services provider's stock valued at $3,440,396,000 after purchasing an additional 162,686 shares during the period. Sanders Capital LLC lifted its holdings in Cigna by 0.3% during the 1st quarter. Sanders Capital LLC now owns 7,479,977 shares of the health services provider's stock worth $1,963,220,000 after buying an additional 21,880 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Cigna by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 5,428,675 shares of the health services provider's stock worth $1,242,969,000 after buying an additional 41,696 shares during the last quarter. Norges Bank purchased a new stake in Cigna during the 4th quarter worth about $747,950,000. Finally, Invesco Ltd. lifted its holdings in Cigna by 25.1% during the 1st quarter. Invesco Ltd. now owns 3,191,358 shares of the health services provider's stock worth $764,682,000 after buying an additional 639,645 shares during the last quarter. 88.57% of the stock is currently owned by hedge funds and other institutional investors.

About Cigna

(Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

See Also

• Get a free copy of the StockNews.com research report on Cigna (CI)
• Why Invest in High-Yield Dividend Stocks?
• Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
• Find and Profitably Trade Stocks at 52-Week Lows
• Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
• 3 Stable Growth Stocks for Bumpy Times

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.